Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Major Bank Ratings | Citi: Reiterates Eli Lilly “Buy” rating, says market concerns over side effects of experimental weight-loss drug are "overreacted"

Major Bank Ratings | Citi: Reiterates Eli Lilly “Buy” rating, says market concerns over side effects of experimental weight-loss drug are "overreacted"

格隆汇格隆汇2026/06/05 02:57
Show original
Glonghui, June 5th|Citi pointed out that investor concerns about abnormal sensations associated with Eli Lilly’s experimental weight-loss drug retatrutide are “somewhat overblown," and added that this signal "does exist, but is of little consequence in the specific context." In recent late-stage clinical data, patients receiving the highest dose of retatrutide lost about 28% of their weight within 80 weeks, with approximately 12.5% of patients in this group experiencing abnormal sensations. Most cases in the late-stage study were mild to moderate, resolved on their own during treatment, and rarely led to discontinuation. The bank also added that this issue is not a risk unique to retatrutide, but a known class effect among other weight-loss medications. Citi stated that more data will be released at the upcoming diabetes conference, which may further highlight the differences between retatrutide and marketed products, and support its wider adoption. The bank reiterated its “Buy” rating on Eli Lilly, with a target price of $1,500.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Jane Dunlevie appointed as Co-Head of TMT Investment Banking at Goldman Sachs (GS.US)

According to reports, Jane Dunlevie, a star investment banker who became a Goldman Sachs partner at age 35, has been appointed as Co-Head of TMT (Technology, Media, and Telecom) Investment Banking, according to an internal Goldman Sachs memo.

智通财经•2026/10/08 07:22

Japan shares extend losses as rate uncertainty, geopolitical woes curb appetite

Updates with closing prices By Satoshi Sugiyama TOKYO, Oct 8 (Reuters) - Japanese shares fell more than 1% on Thursday, down for a second consecutive session, as investors paused after recent rallies, wary of the US rate outlook, higher yields and geopolitical tensions. The Nikkei 225 Index .N225 fell 1.42% to close at 69,042.11, while the broader Topix .TOPX slid 1.51% to 4,091.46. "Japanese shares had risen at a rapid pace through yesterday, and profit-taking has since picked up. That selling pressure appears to be continuing today," said Hiroki Takei, strategist at Resona Holdings. Japanese AI-related shares were subdued even after Samsung Electronics 005930.KS, the world's largest memory chipmaker, projected a nearly ninefold jump in third-quarter operating profit from the same period last year. Shares of chipmaker Rohm 6963.T lost 5.19%, the biggest percentage drag in nearly a month, while technology investor SoftBank Group 9984.T shed 4.28% and Tokyo Electron 8035.T dropped 2.48%. Concerns over US monetary policy remained in focus after Federal Reserve minutes released on Wednesday showed most participants signalling another rate hike by year-end. Market participants remained wary of French and Italian debt markets, with rising energy prices and fiscal concerns keeping sentiment fragile. Geopolitical tensions also dampened risk appetite, as increased attacks on shipping in the Gulf and the Strait of Hormuz fuelled concerns over Middle East oil supplies and pushed crude prices higher. Breadth was negative, with 165 decliners in the Nikkei 225 against 56 advancers and four unchanged. The largest percentage losers in the Nikkei were semiconductor silicon wafer supplier Sumco 3436.T, down 5.73%, followed by construction machinery maker Komatsu 6301.T, down 5.52%, and agricultural machinery and equipment maker Kubota Corporation 6326.T, down 5.42%. The largest percentage gainers were cybersecurity software company Trend Micro 4704.T, up 3.89%, followed by IT consulting firm Nomura Research Institute 4307.T, whic

Reuters•2026/10/08 06:54